MOZOBIL

Google image searchProduct monograph

Active ingredient

plerixafor, 20 MG/ML

DIN: 02377225

Dosage form(s): SOLUTION

Route(s) of administration: SUBCUTANEOUS

Description: 24MG/1.2ML SINGLE USE VIAL

Schedule: Prescription

Company: SANOFI-AVENTIS CANADA INC

Date: 31-JUL-2013

ATC:

• L03 — IMMUNOSTIMULANTS (ATC, ATC/DDD, )
• L03A — IMMUNOSTIMULANTS (ATC, ATC/DDD)
• L03AX — Other immunostimulants (ATC, ATC/DDD)
• L03AX16 — PLERIXAFOR (ATC/DDD)

Reference brand drug: Mozobil

External Links for Mozobil

Search on Google

• Mozobil side effects
• Mozobil dosage
• plerixafor side effects
• plerixafor dosage

Sanofi-Aventis Canada Inc

Go to Sanofi-Aventis website to see drug product details. Sometimes you can find mozobil photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.